Wordt geladen...
Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
BACKGROUND: Diabetic patients present with an accelerated atherosclerotic process and an increased risk for future cardiovascular events. In addition to the risk imposed by the disease itself, pharmacological treatment adds also a sizable risk, especially if certain classes of antidiabetic drugs are...
Bewaard in:
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2012
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3403890/ https://ncbi.nlm.nih.gov/pubmed/22672501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-11-60 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|